Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Translational lung cancer research 2021-06, Vol.10 (6), p.2509-2522
Hauptverfasser: Sánchez-Gastaldo, Amparo, Muñoz-Fuentes, Miguel A., Molina-Pinelo, Sonia, Alonso-García, Miriam, Boyero, Laura, Bernabé-Caro, Reyes
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2522
container_issue 6
container_start_page 2509
container_title Translational lung cancer research
container_volume 10
creator Sánchez-Gastaldo, Amparo
Muñoz-Fuentes, Miguel A.
Molina-Pinelo, Sonia
Alonso-García, Miriam
Boyero, Laura
Bernabé-Caro, Reyes
description
doi_str_mv 10.21037/tlcr-21-156
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8264316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_8264316</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-1402cd9a649df90059401950035e21b61951a98cc70c177946390a0722bdc3333</originalsourceid><addsrcrecordid>eNpVUdtKxDAQDaK4su6bH5APsJqkSdq8CFKvUFRQn0uaptto25Qk6-0P_Guz7iI4L3NgzpyZwwHgCKMTglGanYZeuYTgBDO-Aw4IITyhNMt21xjnCc8YnoGF9y8IIUwFZUzsg1lKiWCc5Qfgu7DO6V4GY0doWzhpZ6ZOO9nDure2gbWxg3Sv2nn4bkIHVW9Go-LYroKyg_bQjPDusSgLOEUVPYYtsTPLDj5cJCWG-mNy2vv1ieC0DLrZUCY91M725ms1yPoQ7LWy93qx7XPwfHX5VNwk5f31bXFeJirlOCSYIqIaITkVTSsQYoIiLBhCKdME1zxiLEWuVIYUzjJBeSqQRBkhdaPSWHNwttGdVvWgGxU_jm6ryZno87Oy0lT_J6PpqqV9q3LCaYp5FDjeCChnvXe6_dvFqPpNpVqnEmEVU0l_AAoFgUI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Sánchez-Gastaldo, Amparo ; Muñoz-Fuentes, Miguel A. ; Molina-Pinelo, Sonia ; Alonso-García, Miriam ; Boyero, Laura ; Bernabé-Caro, Reyes</creator><creatorcontrib>Sánchez-Gastaldo, Amparo ; Muñoz-Fuentes, Miguel A. ; Molina-Pinelo, Sonia ; Alonso-García, Miriam ; Boyero, Laura ; Bernabé-Caro, Reyes</creatorcontrib><identifier>ISSN: 2218-6751</identifier><identifier>EISSN: 2226-4477</identifier><identifier>DOI: 10.21037/tlcr-21-156</identifier><identifier>PMID: 34295658</identifier><language>eng</language><publisher>AME Publishing Company</publisher><subject>Original</subject><ispartof>Translational lung cancer research, 2021-06, Vol.10 (6), p.2509-2522</ispartof><rights>2021 Translational Lung Cancer Research. All rights reserved. 2021 Translational Lung Cancer Research.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-1402cd9a649df90059401950035e21b61951a98cc70c177946390a0722bdc3333</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264316/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264316/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Sánchez-Gastaldo, Amparo</creatorcontrib><creatorcontrib>Muñoz-Fuentes, Miguel A.</creatorcontrib><creatorcontrib>Molina-Pinelo, Sonia</creatorcontrib><creatorcontrib>Alonso-García, Miriam</creatorcontrib><creatorcontrib>Boyero, Laura</creatorcontrib><creatorcontrib>Bernabé-Caro, Reyes</creatorcontrib><title>Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab</title><title>Translational lung cancer research</title><subject>Original</subject><issn>2218-6751</issn><issn>2226-4477</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVUdtKxDAQDaK4su6bH5APsJqkSdq8CFKvUFRQn0uaptto25Qk6-0P_Guz7iI4L3NgzpyZwwHgCKMTglGanYZeuYTgBDO-Aw4IITyhNMt21xjnCc8YnoGF9y8IIUwFZUzsg1lKiWCc5Qfgu7DO6V4GY0doWzhpZ6ZOO9nDure2gbWxg3Sv2nn4bkIHVW9Go-LYroKyg_bQjPDusSgLOEUVPYYtsTPLDj5cJCWG-mNy2vv1ieC0DLrZUCY91M725ms1yPoQ7LWy93qx7XPwfHX5VNwk5f31bXFeJirlOCSYIqIaITkVTSsQYoIiLBhCKdME1zxiLEWuVIYUzjJBeSqQRBkhdaPSWHNwttGdVvWgGxU_jm6ryZno87Oy0lT_J6PpqqV9q3LCaYp5FDjeCChnvXe6_dvFqPpNpVqnEmEVU0l_AAoFgUI</recordid><startdate>202106</startdate><enddate>202106</enddate><creator>Sánchez-Gastaldo, Amparo</creator><creator>Muñoz-Fuentes, Miguel A.</creator><creator>Molina-Pinelo, Sonia</creator><creator>Alonso-García, Miriam</creator><creator>Boyero, Laura</creator><creator>Bernabé-Caro, Reyes</creator><general>AME Publishing Company</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>202106</creationdate><title>Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab</title><author>Sánchez-Gastaldo, Amparo ; Muñoz-Fuentes, Miguel A. ; Molina-Pinelo, Sonia ; Alonso-García, Miriam ; Boyero, Laura ; Bernabé-Caro, Reyes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-1402cd9a649df90059401950035e21b61951a98cc70c177946390a0722bdc3333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Original</topic><toplevel>online_resources</toplevel><creatorcontrib>Sánchez-Gastaldo, Amparo</creatorcontrib><creatorcontrib>Muñoz-Fuentes, Miguel A.</creatorcontrib><creatorcontrib>Molina-Pinelo, Sonia</creatorcontrib><creatorcontrib>Alonso-García, Miriam</creatorcontrib><creatorcontrib>Boyero, Laura</creatorcontrib><creatorcontrib>Bernabé-Caro, Reyes</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Translational lung cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sánchez-Gastaldo, Amparo</au><au>Muñoz-Fuentes, Miguel A.</au><au>Molina-Pinelo, Sonia</au><au>Alonso-García, Miriam</au><au>Boyero, Laura</au><au>Bernabé-Caro, Reyes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab</atitle><jtitle>Translational lung cancer research</jtitle><date>2021-06</date><risdate>2021</risdate><volume>10</volume><issue>6</issue><spage>2509</spage><epage>2522</epage><pages>2509-2522</pages><issn>2218-6751</issn><eissn>2226-4477</eissn><pub>AME Publishing Company</pub><pmid>34295658</pmid><doi>10.21037/tlcr-21-156</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2218-6751
ispartof Translational lung cancer research, 2021-06, Vol.10 (6), p.2509-2522
issn 2218-6751
2226-4477
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8264316
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Original
title Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A20%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correlation%20of%20peripheral%20blood%20biomarkers%20with%20clinical%20outcomes%20in%20NSCLC%20patients%20with%20high%20PD-L1%20expression%20treated%20with%20pembrolizumab&rft.jtitle=Translational%20lung%20cancer%20research&rft.au=S%C3%A1nchez-Gastaldo,%20Amparo&rft.date=2021-06&rft.volume=10&rft.issue=6&rft.spage=2509&rft.epage=2522&rft.pages=2509-2522&rft.issn=2218-6751&rft.eissn=2226-4477&rft_id=info:doi/10.21037/tlcr-21-156&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_8264316%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34295658&rfr_iscdi=true